UK Reveals Seven Partners Whose New Drug Approvals It Will Recognize

The UK regulator, the MHRA, says that while it will recognize drug approvals granted in the EU and a selection of other countries, it will remain a “sovereign regulator” with the ability to reject applications if they don’t meet its standards.

People with joined hands as a team
The UK MHRA is working with other regulators on new drug approvals • Source: Shutterstock

The new international recognition framework to be put in place next year by the UK Medicines and Healthcare products Regulatory Agency will involve seven partners, including countries that are part of the existing international Access Consortium and Project Orbis initiatives, the MHRA has announced.

The partners whose new drug approvals will be recognized by the UK are Australia, Canada, the EU, Japan, Switzerland,

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Europe

More from Geography